ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Imperial Brands PLC (QX)

Imperial Brands PLC (QX) (IMBBF)

29.4563
0.00
(0.00%)
Closed September 24 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
29.4563
Bid
28.75
Ask
30.75
Volume
-
0.00 Day's Range 0.00
19.31 52 Week Range 30.502
Market Cap
Previous Close
29.4563
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
12,561
Shares Outstanding
850,098,962
Dividend Yield
5.26%
PE Ratio
7.99
Earnings Per Share (EPS)
2.74
Revenue
32.48B
Net Profit
2.33B

About Imperial Brands PLC (QX)

Imperial Brands, a FTSE 100 company headquartered in Bristol and London in the UK, is a global consumer goods organisation and the fourth largest international tobacco company. Our core tobacco business is built around a comprehensive portfolio of local and international cigarette brands and other t... Imperial Brands, a FTSE 100 company headquartered in Bristol and London in the UK, is a global consumer goods organisation and the fourth largest international tobacco company. Our core tobacco business is built around a comprehensive portfolio of local and international cigarette brands and other tobacco products and smoking accessories available in around 120 markets worldwide. Aligned with our purpose to forge a path to a healthier future for moments of relaxation and pleasure, we are also committed to building a sustainable next generation product (NGP) business, offering smokers a targeted range of potentially less harmful alternatives to traditional tobacco products. In January 2021 Imperial outlined a new five-year strategy to transform the business and enhance its investor proposition by building a stronger and more consumer-focused business. Our clear capital allocation framework supports investment in our new strategy, maintains a strong and efficient balance sheet and delivers enhanced shareholder returns. We focus our investment and resources around our five most important markets of USA, Germany, UK, Australia and Spain, and seek to drive value from our broader market portfolio. Imperial is comprised of three geographic operating segments Europe; Americas; and Africa, Asia, Australasia & Central / Eastern Europe (AAACE). In addition, our Distribution segment consists of our 50.01% stake in Logista, one of the largest logistics businesses in Europe. Show more

Sector
Cigarettes
Industry
Tobacco Products
Headquarters
Bristol, Gbr
Founded
1996
Imperial Brands PLC (QX) is listed in the Cigarettes sector of the OTCMarkets with ticker IMBBF. The last closing price for Imperial Brands (QX) was $29.46. Over the last year, Imperial Brands (QX) shares have traded in a share price range of $ 19.31 to $ 30.502.

Imperial Brands (QX) currently has 850,098,962 shares outstanding. The market capitalization of Imperial Brands (QX) is $25.04 billion. Imperial Brands (QX) has a price to earnings ratio (PE ratio) of 7.99.

IMBBF Latest News

Definitive Agreement Marks Milestone for Alternative Nicotine Delivery Options

NetworkNewsWire Editorial Coverage: In a country where the life-threatening risks of smoking are well-known and 22 million smokers want to quit, a milestone agreement between a drug delivery...

Piggyback Qualified

Sun, Sep 15, 2013 12:00 - Imperial Tobacco Group PLC (ITYBF: OTC Pink Current) - Piggyback Qualified - Effective Sun, Sep 15, 2013, ITYBF is designated with the status of piggyback qualified...

Venue Change

Fri, Aug 16, 2013 12:00 - Imperial Tobacco Group PLC (ITYBF: OTC Link) - Venue Change - The symbol, ITYBF, no longer trades on Grey Market. As of Fri, Aug 16, 2013, ITYBF trades on OTC Link. You...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.5237-1.7468312208129.9829.9828.458136828.87490213CS
40.85632.9940559440628.630.50227.811898229.26371211CS
124.446317.778088764525.0130.50224.8451256128.4350696CS
267.816336.119685767121.6430.50220.77865626.51963024CS
528.736342.163610038620.7230.50219.311754623.41624101CS
1568.456340.26809523812130.50218.75351215323.24939885CS
2604.106516.199338850825.349830.50214.681131722.19918314CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AABVFAberdeen International Inc (PK)
$ 0.03115
(0.00%)
0
AABKFAareal Bank AG (PK)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.03295
(0.00%)
0
AAALYAareal Bank AG (PK)
$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
$ 0.03115
(0.00%)
0
AABKFAareal Bank AG (PK)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.03295
(0.00%)
0
AAALYAareal Bank AG (PK)
$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
ASCCFAsics Corporation (PK)
$ 18.50
(0.00%)
192.48k
OSCUFJapan Exchange Group Inc (PK)
$ 25.25
(0.00%)
68.22k
SMFNFSumitomo Mitsui Finl (PK)
$ 61.79
(0.00%)
26.15k
DIDIYDiDi Global Inc (PK)
$ 4.05
(0.00%)
14.7k
SNEJFSony Group Corporation
 95.526
(0.00%)
14.29k

Discussion

View Full Feed
MADDSTACKER MADDSTACKER 5 minutes ago
Great news :)
VFF
PRCubaDog PRCubaDog 5 minutes ago
This is pumper boys way of saying he lied and hasn't bought a share in years. 🤣🤣🤣 BK IMMINENT!
INNDD
fuagf fuagf 5 minutes ago
You're right, two good posts by you questioning OMOLIVE's position, the first here ..

I don't understand what you are trying to prove.

2) Gradual increase in the age of eligibility for full benefits to age 66 in 2009 and to age 67 in 2027. The earnings test will also b
jackson73 jackson73 5 minutes ago
SEEL .41 ww on news out
RIGATONI RIGATONI 5 minutes ago
$6.68 with a new high on news...


Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

https://finance.yahoo.com/news/capricor-therapeutics-ann
CAPR
JohnSmith4 JohnSmith4 5 minutes ago
BAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHHAHAHAHAHAHAHAHAHAHHAHA
TSOI
subslover subslover 6 minutes ago
I told that dog over 1 month ago to call a plumber. He got upset with at that statement so Roto-Rooter never showed
MLGO
2020trader 2020trader 6 minutes ago
this truly a garbage stock
CLNV
DGJR DGJR 6 minutes ago
Where does it show how many shares he sold and or transferred to others, show the proof.
AABB
Volcano Volcano 6 minutes ago
Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, announced today, following recent meetings with the U.S. Food and Drug Administration (FDA), its intent to file a Biologics License Applicat
CAPR
mascale mascale 7 minutes ago
The actual "Gold Standard" in electrical conductors is Copper.
HIRU
bigstocksnbonds bigstocksnbonds 7 minutes ago
Oct 25 is great!!

Congrats on ALL!!!!!!!
cottonmather cottonmather 7 minutes ago
Langley Outdoors. Polls suggest a Trump win. 11 minutes https://www.youtube.com/watch?v=rt85n0Zfmts
TheKid5 TheKid5 7 minutes ago
No funding. WV is dead. 1 year wasted. the future is bright
CLNV
toogoodfella toogoodfella 7 minutes ago
RE:.. The distribution of about 1M or more maybe the final.

—//——-//—-

CORRECTION: “100M or more”
LEHNQ
2020trader 2020trader 7 minutes ago
expecting lower today
SINC
Mufaso Mufaso 7 minutes ago
One thing I need to correct is that the allegation Toexane is making about stocking. The SEC filing says

...including breaches of the maximum levels of buffer stock...

The normal stocking problem you have with a distributor is that they don't have enough. In this
RVNC
jay_tee jay_tee 7 minutes ago
Go retake PUMP 101
RNVA
2020trader 2020trader 8 minutes ago
guaranteed
SINC
carolinatiger carolinatiger 8 minutes ago
As I continue to say. But yet, you are here. Everyone knows why.
IGPK
TheKid5 TheKid5 8 minutes ago
Great call! The future is bright! Funding any day now.
CLNV
RIGATONI RIGATONI 8 minutes ago
First news in a long time...

Do the dd while its still down here

https://x.com/rigatoni33/status/1838551947172860017
Volcano Volcano 8 minutes ago
Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, announced today, following recent meetings with the U.S. Food and Drug Administration (FDA), its intent to file a Biologics License Applicat
CAPR
nagoya1 nagoya1 9 minutes ago
Without being cheeky, I stuck that K suppository where it belongs.
FNMA
FNMA
MartinLutherKing MartinLutherKing 9 minutes ago
Last call ALL aboard FOXO NYSE Spaceship AI medical revelation
FOXO

Your Recent History

Delayed Upgrade Clock